SPARC Site 22 — Roswell, Georgia

SPARC Site 22 is a clinical research site located in Roswell, Georgia, United States 30076.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

SPARC Site 22 has participated in 1 clinical trials.

Therapeutic areas: Open Angle Glaucoma, Ocular Hypertension.

Sponsors: Sun Pharma Advanced Research Company Limited.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for SPARC Site 22?

SPARC Site 22 has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has SPARC Site 22 conducted?

SPARC Site 22 has 1 clinical trials on record. Their work covers Open Angle Glaucoma, Ocular Hypertension.

Is SPARC Site 22 accredited by Crixeo Health?

SPARC Site 22 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about SPARC Site 22?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.